TABLE 3

Diagnostic accuracy in in patients with different asthma phenotypes

ObesityAtopyAsthma severitySmoking status
NonobeseObesep-valueNonatopicAtopicp-valueMild–moderateSeverep-valueNever-smokerEx- or current smokerp-value
Eosinophilia (<3%/≥3%)154/8266/340.90153/7467/420.28161/5858/57<0.01103/51117/650.62
FeNO0.83 (0.77–0.88)0.78 (0.68–0.89)0.460.83 (0.77–0.89)0.78 (0.69–0.88)0.400.81 (0.74–0.88)0.83 (0.75–0.91)0.670.84 (0.77–0.90)0.81 (0.73–0.88)0.52
Blood eosinophils0.83 (0.77–0.89)0.82 (0.73–0.91)0.820.83 (0.77–0.89)0.83 (0.74–0.91)0.990.82 (0.76–0.89)0.80 (0.72–0.89)0.730.86 (0.79–0.93)0.80 (0.73–0.87)0.23
IgE0.73 (0.67–0.80)0.59 (0.47–0.70)0.030.75 (0.68–0.82)0.57 (0.46–0.68)<0.010.68 (0.61–0.76)0.66 (0.56–0.76)0.700.64 (0.55–0.73)0.74 (0.66–0.81)0.13
FeNO + blood  eosinophils0.88 (0.83–0.93)0.85 (0.76–0.93)0.550.88 (0.82–0.92)0.85 (0.77–0.93)0.630.86 (0.81–0.92)0.85 (0.78–0.92)0.810.88 (0.82–0.94)0.86 (0.80–0.92)0.64
  • Data are presented as n or area under the curve (AUC) (95% CI), unless otherwise stated. AUC (95% CI) is given per biomarker in every subgroup. The difference between the AUCs for every biomarker is compared within the separate subgroups and the result depicted as p-value. Bold type represents statistical significance. FeNO: exhaled nitric oxide fraction; Ig: immunoglobulin.